4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-115368
EVP, Head of North America sold 80 shares at $28.00 ($2,240)
- EVP, Head of North America acquired 80 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lee Jennifer Kayden EVP, Head of North America | 2023-11-03 | Option exercise 10b5-1 | +80 | $6.80 | $544 | 1,727 | D |
| Lee Jennifer Kayden EVP, Head of North America | 2023-11-03 | Sale 10b5-1 | −80 | $28.00 | $2,240 | 1,647 | D |
| Derivatives | |||||||
| Lee Jennifer Kayden EVP, Head of North America | 2023-11-03 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −80 | 67,592 | D | ||
| Open-market sales · 80 sh · avg $28.00 · $2,240 | |||||||
Loading xslF345X05/tm2330154-1_4seq1.xml…